ARDT
$12.12+3.68%
ARDT — Ardent Health Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEE
10.012.014.016.018.020.002.0M4.0M$12.12—202420252026
2026-10-20
Price$12.12
MA20$11.01
MA50$10.53
Vol343.1K
Key stats#
Price data
- Price
- $12.12
- YTD price return
- +37.26%
- YTD total return
- +37.26%
- Next earnings
- Nov 4, 2026 · After close
- Market cap
- 1.7B
- Enterprise value
- 3.7B
- Shares outstanding
- 141M
- 52W low
- $7.71
- 52W high
- $15.48
- From 52W high
- -21.71%
- From 52W low
- +57.20%
- 52W range
- 57%
Volume
- Rel volume
- 0.71×
- 30D volume
- 482.4K
- 30D $ vol
- 5.3M
Fundamentals
- Sales (ttm)
- 6.4B
- Sales/share
- $45.42
- EPS (ttm)
- $0.55
- FCF (ttm)
- 470.5M
- FCF/share
- $3.34
- Book value/share
- $9.58
- Net margin
- 1.22%
- ROE
- 5.79%
- ROA
- 1.48%
- Debt / equity
- 0.79×
- Current ratio
- 2.10
Growth (CAGR, ttm) · 10Y
- Sales
- +3.35%+6.56%n/an/a
- Net income
- -69.33%-22.29%n/an/a
- Shares
- -1.44%+3.80%n/an/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -69.73%-24.92%n/an/a
- Sales/share
- +4.86%+3.20%n/an/a
- Book value/share
- +9.23%+4.33%n/an/a
- Price
- -17.56%-11.73%n/an/a
- Total return
- -17.56%-11.73%n/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 22.0×
- Fwd P/E
- 9.7×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 1.3×
- P/FCF (ttm)
- 3.6×
- EV/Sales (ttm)
- 0.6×
- FCF yield (ttm)
- 27.52%
- Buyback yield (realized, 1y)
- 1.44%
- Shareholder yield (realized, 1y)
- 1.44%
- Buyback yield (cash, ttm)
- 0.76%
- Shareholder yield (cash, ttm)
- 0.76%
Performance · price return · as of 2026-10-20#
1D
+3.68%
5D
+3.68%
1M
+15.65%
3M
+16.09%
YTD
+37.26%
1Y
-17.55%
5Y
—
Financial statements
Open full ARDT financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
